Price to Book Value Chart

View Price to Book Value for TLRY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to Book Value Chart
Start Trial

Historical Price to Book Value Data

View and export this data back to 2018. Start Trial.
Date Value
August 24, 2026 0.3833
August 21, 2026 0.393
August 20, 2026 0.3792
August 19, 2026 0.3922
August 18, 2026 0.363
August 17, 2026 0.3638
August 14, 2026 0.3792
August 13, 2026 0.3817
August 12, 2026 0.38
August 11, 2026 0.3882
August 10, 2026 0.3589
August 07, 2026 0.3711
August 06, 2026 0.3606
August 05, 2026 0.3593
August 04, 2026 0.3768
August 03, 2026 0.3768
July 31, 2026 0.3687
July 30, 2026 0.3411
July 29, 2026 0.324
July 28, 2026 0.3273
July 27, 2026 0.3273
July 24, 2026 0.3151
July 23, 2026 0.324
July 22, 2026 0.3378
July 21, 2026 0.3443
Date Value
July 20, 2026 0.3435
July 17, 2026 0.3492
July 16, 2026 0.3532
July 15, 2026 0.3557
July 14, 2026 0.3557
July 13, 2026 0.3622
July 10, 2026 0.3589
July 09, 2026 0.3565
July 08, 2026 0.3549
July 07, 2026 0.35
July 06, 2026 0.3557
July 02, 2026 0.3752
July 01, 2026 0.3597
June 30, 2026 0.3646
June 29, 2026 0.3744
June 26, 2026 0.3768
June 25, 2026 0.3622
June 24, 2026 0.3727
June 23, 2026 0.3744
June 22, 2026 0.3727
June 18, 2026 0.3841
June 17, 2026 0.3857
June 16, 2026 0.3963
June 15, 2026 0.4068
June 12, 2026 0.4044

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
SNDL, Inc. 0.4511
cbdMD, Inc. 0.6608
Clearmind Medicine, Inc. 0.149
CannaPharmaRx, Inc. --
Cosmos Health, Inc. 0.8062

Price to Book Value Related Metrics

PS Ratio 0.573
Price 4.72
Earnings Yield -22.78%
Market Cap 618.76M